Skip to main content

Shanghai Pharma Services Provider to Use IDBS' Software

NEW YORK (GenomeWeb news) – IDBS said today that the Chinese contract research organization PharmaLegacy Laboratories will use its E-Workbook Suite to handle information for its pharmacology services.
 
Shanghai-based PharmaLegacy will use the company’s preclinical data management suite, including the BioBook biology extension software.
 
IDBS said the E-WorkBook suite will help the drug developer to “increase client productivity and the pace of drug development by providing effective management and analysis of complex research data.”
 
PharmaLegacy’s VP of Corporate Planning, Tom Tillotson, said in a statement that BioBook will enable the CRO to “develop long-term partnerships with biotechnology and pharmaceutical clients.”
 
Financial terms of the agreement were not released.

The Scan

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.